OBJECTIVE— Viral infections contribute to the pathogenesis of type 1 diabetes. Viruses, or viral products such as double-stranded RNA (dsRNA), affect pancreatic β-cell survival and trigger autoimmunity by unknown mechanisms. We presently investigated the mediators and downstream effectors of dsRNA-induced β-cell death.

RESEARCH DESIGN AND METHODS— Primary rat β-cells and islet cells from wild-type, toll-like receptor (TLR) 3, type I interferon receptor (IFNAR1), or interferon regulatory factor (IRF)-3 knockout mice were exposed to external dsRNA (external polyinosinic-polycytidylic acid [PICex]) or were transfected with dsRNA ([PICin]).

RESULTS— TLR3 signaling mediated PICex-induced nuclear factor-κB (NF-κB) and IRF-3 activation and β-cell apoptosis. PICin activated NF-κB and IRF-3 in a TLR3-independent manner, induced eukaryotic initiation factor 2α phosphorylation, and triggered a massive production of interferon (IFN)-β. This contributed to β-cell death, as islet cells from IFNAR1−/− or IRF-3−/− mice were protected against PICin-induced apoptosis.

CONCLUSIONS— PICex and PICin trigger β-cell apoptosis via the TLR3 pathway or IRF-3 signaling, respectively. Execution of PICin-mediated apoptosis depends on autocrine effects of type I IFNs.

Type 1 diabetes is an immune-mediated disease resulting from the loss of insulin-producing pancreatic β-cells. Besides genetic susceptibility, environmental factors play a role in the development of type 1 diabetes. Several studies (1,2) have implicated viral infections in the pathogenesis of the disease. Insulin-producing β-cells are highly susceptible to enteroviral infections, and studies (3,4) on postmortem pancreatic specimens of type 1 diabetic patients demonstrated enterovirus RNA–positive cells in islet cells but not in the exocrine pancreas. During viral infection, the local production of cytokines by both invading immune cells and the pancreatic β-cells themselves interact to initiate and/or accelerate the transition from innate immune response to the chronic autoimmune assault (5). The molecular mechanisms involved in these steps remain to be clarified.

Double-stranded RNA (dsRNA) is generated during the life cycle of most viruses, and it accumulates in and around infected cells during viral infections (6,7). The antiviral activities induced by dsRNA are mimicked by polyinosinic-polycytidylic acid (PIC), a synthetic dsRNA. In vivo, PIC triggers hyperglycemia in diabetes-resistant BB rats and accelerates the development of diabetes in diabetes-prone BB rats (8,9); in vitro, PIC inhibits glucose-stimulated insulin biosynthesis (10) and, when used in combination with interferon (IFN)-γ, impairs islet cell function and viability (11).

Toll-like receptors (TLRs) act as sensors of microbial components and mediate innate and adaptive immunity, modulating production of proinflammatory cytokines and chemokines (12). TLR3 is involved in the cellular recognition of viral dsRNA, and both cytosolic dsRNA and dsRNA released from dying/damaged cells serve as TLR3 ligands. Expression of TLRs in rodent and human pancreatic islets was recently described (1315). dsRNA or viral infection increase expression of mRNAs encoding for TLR3 and for genes downstream of its signaling pathway in rat and human β-cells (13,16). dsRNA-induced activation of TLR3 leads to activation of nuclear factor-κB (NF-κB) and of IFN regulatory factor (IRF) 3 in other cell types (17,18). Activated IRF-3 and NF-κB translocate to the nucleus and induce type I IFN expression. Secreted IFN-α and -β stimulate the expression of IFN-inducible genes, such as proinflammatory cytokines and chemokines (19). Type I IFNs have been implicated as potential mediators of viral/dsRNA-induced type 1 diabetes (2022).

In the present study, we characterized the early mediators and downstream effectors of dsRNA-induced apoptosis in primary pancreatic β-cells. Both fluorescence-activated cell sorting (FACS)-purified rat β-cells and islet cells isolated from wild-type and TLR3, IRF-3, or type I IFN receptor (IFNAR1) knockout mice were studied. Cells were exposed to either dsRNA added in the culture medium (external dsRNA; PICex) in the absence or presence of IFN-γ or were subjected to dsRNA transfection using lipofectamine (LF) (internal dsRNA; PICin). The data obtained indicate major differences in the signaling of internal and external dsRNA and point to novel mechanisms by which this crucial byproduct of viral infection triggers β-cell apoptosis and contributes for initiation/amplification of inflammation and insulitis.

Animals.

Adult male Wistar rats (Charles River Laboratories, Brussels, Belgium), wild-type C57BL/6 mice (Harlan CBP, Zeist, the Netherlands), TLR3−/− mice (23), IRF-3−/− mice (Riken BioResource Center, Ibaraki, Japan, with the approval of T. Taniguchi, University of Tokyo), and IFNAR1−/− mice (received from C. Libert, courtesy of Dr. Demengeot, Instituto Gulbenkian de Ciencia, Oeiras, Portugal) were housed and used according to the guidelines of the Belgian regulations for animal care. The number of islets obtained per pancreas was comparable among wild-type, TLR3−/−, IFNAR1−/−, and IRF3−/− mice (online appendix Table S1 [available at http://dx.doi.org/10.2337/db07-0844]). Glycemia in the fed state was somewhat higher in TLR3−/− and IRF-3−/− mice when compared with wild-type mice (online appendix Table S1), but TLR3−/− mice showed a normal glucose tolerance test (online appendix Fig. S1). Islet histology was similar in wild-type and TLR3−/− mice (not shown).

Islet cell isolation and culture.

Pancreatic islets were isolated by collagenase digestion, and β-cells were purified by autofluorescence-activated cell sorting (FACStar; Becton Dickinson, Sunnyvale, CA) as previously described (13,24). Purified β-cells (>90% pure) were cultured in HAM's F-10 medium (Cambrex Bio Science, Verviers, Belgium) supplemented with 10 mmol/l glucose, 2 mmol/l l-glutamine, 0.5% BSA, 50 μmol/l 3-isobutyl-1-methylxanthine, 50 units/ml penicillin, and 50 μg/ml streptomycin. During the first 36 h of culture, 5% heat-inactivated fetal bovine serum was added.

Assessment of IFN-β production and cell viability.

Rat β-cells or mouse dispersed islet cells (104 cells per well) were cultured in Falcon 96-well microtiter plates precoated with poly-l-lysine. Cells were maintained in control condition or were exposed to external dsRNA (PICex; 100 μg/ml; Sigma), IFN-γ (500 units/ml; R&D Systems, Oxon, U.K.), and/or interleukin (IL)-1β (50 units/ml; NCI, National Institutes of Health, Bethesda, MD). The medium was replaced every 2 days. Foreign dsRNA was introduced into the cells (PICin) by treating them for 4 h with a mix of LF and PIC (1 μg/ml for rat β-cells and 10 μg/ml for mouse dispersed islet cells); control cells were treated with LF alone or left untreated. Selection of intra- and extracellular PIC concentrations was based on dose-response studies (data not shown). The PIC-transfected cells were then maintained in culture (see above) for up to 5 days. In some experiments, an antibody raised against rat IFN-β (10 μg/ml; PBL Biomedical Laboratories, Piscataway, NJ) was added to the culture medium.

After 2 and 5 days’ culture, cell supernatants were pooled and murine IFN-β was measured by enzyme-linked immunosorbent assay (PBL Biomedical Laboratories). The percentage of viable, apoptotic, or necrotic cells was assessed by incubation for 15 min with propidium iodide (10 μg/ml) and Hoechst 342 (10 μg/ml) (25,26). Counting of viable, apoptotic, and necrotic cells was done by two observers, with one of them unaware of the tested conditions. At least 500 cells were counted per experimental condition, and the agreement between the observers was always >90%. Similar amounts of apoptosis were obtained via determination of caspase 3 activation using the NunView 488 Caspase-3 Kit for Live Cells (data not shown; Biotium, Hayward, CA).

RT-PCR and real-time RT-PCR.

Semiquantitative RT-PCR was done using poly(A)+ RNA as described (27). The primer sequences for amplification of rat cDNAs for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (13), TLR3 (13), and dsRNA-dependent protein kinase (PKR) (28) were described in the indicated references. Expression of the housekeeping gene GAPDH is not affected by exposure to dsRNA (26) and was used as a control. Real-time RT-PCR for IFN-α, IFN-β, CCAAT/enhancer-binding protein homologous protein (CHOP), activating transcription factor-4 (ATF-4), Bip, X-box binding protein-1 spliced, and GAPDH was done as described (13,29).

Immunocytochemistry.

FACS-purified rat β-cells or dispersed mouse islet cells were fixed with 4% formaldehyde and permeabilized with a mix of 70% acetone and 30% methanol. The cells were blocked with PBS containing 0.8% BSA and 10% normal goat serum and then incubated with a rabbit antibody raised against the p65 subunit of NF-κB (C-20; Santa Cruz) alone or in combination with a mouse antibody recognizing insulin (clone K36AC10; Sigma) at 1/500 or 1/1,000 dilution in PBS, respectively. After washing, cells were incubated with goat anti-rabbit Alexa 488 (used at 1/500 dilution; Molecular Probes) alone or in combination with donkey anti-mouse rhodamine (used at 1/200 dilution; Jackson Laboratories). The cells were visualized at a magnification of ×40 with a Zeiss Axiovert 200 microscope (Germany). The number of negative and positive cells for NF-κB nuclear localization was evaluated by two observers (one of them unaware of the tested conditions) who counted at least 300 cells for each experimental condition.

Western blot analysis and protein biosynthesis.

Total cell extracts were prepared by lysing equal numbers of cells (30,31). The following primary antibodies were used: rabbit polyclonal antibodies to phospho (p)-IRF-3 (Ser396, no. 4961; Cell Signaling), p–eukaryotic initiation factor (eIF) 2α (Ser51, no. 9721; Cell Signaling), total eIF2α (FL-315; Santa Cruz), or β-actin (no. 4967; Cell Signaling) at 1/1,000 dilution and horseradish peroxidase–conjugated donkey anti-rabbit antibody (Amersham Life Science, Amersham, U.K.) at 1/5,000 dilution. The membranes were incubated with detection system of enhanced chemiluminescence (SuperSignal West Femto Maximum Sensitivity Substrate; Pierce). The protein-specific signals were quantified using Biomax1D image analysis software (Kodak). Total protein biosynthesis was determined in the presence of 10.0 mmol/l glucose using l-[4,5-3H] leucine incorporation and trichloroacetic precipitation, as previously described (32). As a positive control for protein biosynthesis inhibition, cells were exposed to cycloheximide (10 μmol/l).

Statistical analysis.

Data are presented as means ± SE. Statistical differences between groups were determined either by paired Student's t test or by one-way ANOVA, followed by Student's t test with the Bonferroni correction, as indicated. A P value of <0.05 was considered statistically significant.

dsRNA induces apoptosis in pancreatic β-cells.

Exposure of purified rat β-cells to PICex (100 μg/ml) for 5 days induced a less than twofold increase in apoptosis (Fig. 1A); this effect was magnified fourfold by IFN-γ (Fig. 1A). There was a sevenfold increase in apoptosis when foreign dsRNA was introduced into β-cells by lipofection (PICin) (Fig. 1A). IFN-γ treatment alone did not affect cell viability (Fig. 1A). Addition of 1 mmol/l monomethyl-l-arginine, an inhibitor of the inducible form of nitric oxide (NO) synthase, did not prevent PICin-induced β-cell death (Fig. 1A). Similar results were observed in β-cells exposed to PICex+IFN-γ (26), suggesting that the proapoptotic effects of both PICex and PICin are NO independent. No significant modifications in β-cell necrosis were observed in any of the experimental conditions tested (data not shown).

To evaluate whether the detrimental effects of PICex and PICin on β-cell viability are mediated via the TLR3 pathway, dispersed islet cells isolated from wild-type or TLR3 knockout (TLR3−/−) mice were utilized. As observed in rat β-cells (Fig. 1A), exposure of wild-type mouse islet cells to PICex+IFN-γ induced a clear increase in apoptosis (Fig. 1B). Disruption of the TLR3 pathway prevented the deleterious effects of PICex+IFN-γ (Fig. 1B). PICin-induced apoptosis was partially prevented by TLR3 disruption, but the percentage of cell death remained higher than in control cells (Fig. 1B). Suppression of the TLR3 pathway did not protect against IL-1β+IFN-γ–induced cell death, which was used as a positive control. These results demonstrate that TLR3 mediates both PICex- and PICin-induced apoptosis; in the latter case, however, other pathway(s) contribute to β-cell death.

TLR3 is required to activate NF-κB in response to dsRNA.

Activation of the transcription factor NF-κB is a key mediator of β-cell apoptosis induced by cytokines or PICex (33,34). We therefore analyzed whether dsRNA activates NF-κB in purified rat β-cells. Both PICex- and PICin-induced nuclear translocation of NF-κB in β-cells (54 ± 12 and 80 ± 6% positive cells, respectively; P < 0.05 and P < 0.005 vs. control, respectively; n = 4), while IL-1β, used as positive control, activated NF-κB in 86 ± 7% of the cells (P < 0.005 vs. control; n = 3). To examine whether dsRNA-induced activation of NF-κB depends on TLR3 signaling, dispersed islet cells from wild-type or TLR3−/− mice were evaluated (Fig. 2). NF-κB activation was induced by both PICex and PICin in wild-type cells, with a more potent effect of PICin (Fig. 2B).

In TLR3−/− cells, PICex failed to activate NF-κB (Fig. 2A and B), while PICin induced NF-κB nuclear translocation in 63 ± 6% of the cells (Fig. 2B). NF-κB activation by PICin, however, was somewhat lower in TLR3−/− than in wild-type cells (Fig. 2B). IL-1β–induced NF-κB activation, used as positive control, was similar in TLR3−/− and wild-type cells (data not shown). Of note, inhibition of NF-κB activation by the use of an adenoviral construct expressing a nondegradable form of IκBα (33) did not prevent PICin-induced apoptosis (online appendix Fig. S2), suggesting that NF-κB activation is not a key mediator of PICin-triggered β-cell death. These results demonstrate that in β-cells PICex activates NF-κB exclusively via TLR3 signaling, while PICin-induced NF-κB activation depends both on TLR3 and on other pathways.

TLR3 mediates external, but not internal, dsRNA-induced IRF-3 activation in β-cells.

IRF-3 is an ubiquitous transcriptional regulator constitutively expressed in the cytosol. Stimulation of TLR3 induces IRF-3 phosphorylation, nuclear translocation, and production of type I IFNs (35). As shown in Fig. 3A, treatment of rat β-cells with PICex or PICin induced IRF-3 phosphorylation. Following correction for β-actin expression, PICin induced a higher activation of IRF-3 than PICex in both wild-type mouse and rat β-cells (Fig. 3A and B). To investigate the role of TLR3 in dsRNA-mediated IRF-3 activation, islet cells from wild-type and TLR3−/− mice were treated with external or internal PIC. As shown in Fig. 3B, exposure to PICex for 4 h induced IRF-3 phosphorylation in wild-type cells but not in TLR3−/− cells. On the other hand, IRF-3 activation was observed after PICin treatment in both wild-type and TLR3−/− islet cells (Fig. 3B). These results indicate that IRF-3 activation by PICex depends on TLR3 stimulation, while PICin induces IRF-3 phosphorylation via TLR3-independent mechanism(s).

Suppression of IRF-3 signaling prevents internal dsRNA-induced β-cell apoptosis.

To evaluate the role of IRF-3 signaling in dsRNA-mediated apoptosis, islet cells were isolated from wild-type and IRF-3−/− mice. As shown in Fig. 4, exposure to PICex+IFN-γ induced a comparable degree of apoptosis in wild-type and IRF-3−/− islet cells. On the other hand, PICin markedly increased apoptosis in wild-type cells but failed to trigger cell death in IRF-3−/− cells (Fig. 4). To further examine whether the IRF-3 pathway plays a role in the deleterious effects of PIC on β-cell function, glucose-stimulated insulin secretion was performed in islet cells isolated from wild-type and IRF-3−/− mice. The insulin content of islet cells was not affected by IFN-γ and PICex+IFN-γ treatment in both cell types (online appendix Table S2). Exposure to PICex or PICin decreased insulin content in wild-type (P < 0.05 and P < 0.005 vs. control, respectively; n = 12) but not in IRF-3−/− (P > 0.05; n = 9) (online appendix Table S2) cells.

Basal insulin release was similar between wild-type and IRF3−/− cells and was not affected by the different experimental conditions (Fig. 5A and B). Exposure to glucose plus forskolin increased insulin secretion by threefold in control wild-type and IRF-3−/− islet cells (Fig. 5A and B). Stimulated insulin release was decreased after exposure to PICex+IFN-γ in both cell types (Fig. 5A and B), as previously reported for wild-type islets (10,11,36). In islet cells isolated from wild-type mice, PICin treatment caused a trend (P = 0.07) for a decrease in glucose plus forskolin–induced insulin secretion when compared with control cells (Fig. 5A). By contrast, insulin release was not affected by PICin in IRF-3−/− islet cells (P = 0.181) (Fig. 5B). Islet cells from IRF-3−/− mice are thus more resistant to the deleterious effects of PICin on viability and function, while they are affected in a similar way as wild-type islet cells when exposed to PICex+IFN-γ (Figs. 4 and 5) (online appendix Table S2). Taken together, these data suggest a key role for IRF-3 signaling in internal dsRNA-induced β-cell dysfunction and death, while IRF-3 plays a minor role in β-cell apoptosis triggered by PICex+IFN-γ.

Autocrine production of IFN-β contributes to dsRNA-induced apoptosis.

Exposure of β-cells to PICex increased expression of IFN-α and IFN-β 2–10 times above control values, while PICin induced a 50- to 2,000-fold upregulation of type I IFN mRNAs (Fig. 6A and B). Genes downstream of dsRNA signaling, including PKR, TLR3, and RANTES, were upregulated to the same extent by PICex and PICin (data not shown). In line with these data, IFN-β production by PICin-treated mouse islet cells was 58.1 ± 8.1 pg · 103 cells−1 · 5 days−1 (Fig. 6C), while it was below detection in wild-type islet cells exposed to PICex or in control condition. Of interest, IFN-β secretion was markedly reduced in TLR3−/− islet cells treated with PICin and it was virtually absent in IRF-3−/− mice (Fig. 6C).

To further evaluate the role of such a massive autocrine production of type I IFNs in PICin-induced apoptosis, islet cells from wild-type or IFNAR1−/− mice were treated with PICin for 5 days. IFNAR1−/− cells were protected against PICin-induced apoptosis (Fig. 6D). Of note, IFNAR1−/− cells secreted five times less IFN-β than wild-type cells (Fig. 6C). In accordance with these observations, an antibody raised against rat IFN-β also induced a 70% protection against PICin-induced apoptosis (online appendix Fig. S3). These results show that PICin markedly upregulates IFN-α/β mRNA expression and triggers secretion of IFN-β by β-cells. IFN-β production is regulated by IRF-3 signaling and, to a lesser extent, through TLR3 stimulation. These data suggest that execution of PICin-induced β-cell apoptosis depends on autocrine effects of type I IFNs.

Internal dsRNA induces eIF2α phosphorylation, inhibits protein biosynthesis, and upregulates endoplasmic reticulum stress marker genes in β-cells.

Exposure of β-cells to PICex did not induce eIF2α phosphorylation, while internalization of dsRNA resulted in a rapid phosphorylation of eIF2α, which persisted through 4 h before returning to basal level (Fig. 7A). In line with these data, PICin reduced protein biosynthesis to 50% of the control value (Fig. 7B), while PICex induced a less marked decrease in protein biosynthesis (Fig. 7B). Cycloheximide suppressed translation by 90% (Fig. 7B).

To evaluate whether eIF2α phosphorylation was part of a broader endoplasmic reticulum (ER) stress response, we examined the expression of four ER stress–related genes. As shown in Fig. 8, PICin markedly induced expression of the transcription factors ATF-4 (Fig. 8A) and CHOP (Fig. 8B) and of the ER chaperone Bip (Fig. 8D). Activation of the ER stress response was confirmed by increased expression of the spliced form of X-box binding protein-1 (Fig. 8C). Exposure to PICex did not affect expression of these genes (Fig. 8A–D).

Epidemiological evidence, postmortem studies, and in vitro experimental data support the hypothesis that enterovirus infections play a role in the development of type 1 diabetes. The molecular mechanisms involved in viral/dsRNA-mediated β-cell apoptosis and in triggering the early cellular events that will lead to insulitis and autoimmunity, however, remain to be clarified.

TLR3 recognizes viral and synthetic dsRNA and plays an important role in the cellular responses to several viruses (37,38). The existence of viral evasion mechanisms targeting the TLR3 pathway confirms that TLR3 signaling is a key component of the host antiviral response (39). We have shown that TLR3 is expressed and functional in pancreatic β-cells (13 and present data).

To dissect the signaling pathways downstream of dsRNA in pancreatic β-cells, we used dsRNA, tested in the form of PIC, either added to the extracellular medium or introduced in the cytosolic compartment by lipofection. PICex, when tested alone, induces a minor increase in β-cell apoptosis; in the presence of IFN-γ, however, it induces apoptosis in >50% of the cells. Similar results were previously observed in the presence of type I IFNs plus dsRNA (13). Disruption of the TLR3 pathway completely abrogates PICex+IFN-γ–induced cell death (present data). Stimulation of TLR3 by PICex activates NF-κB and IRF-3. Inhibition of NF-κB activation prevents both cytokine- and PICex+IFN-γ–induced β-cell apoptosis, suggesting that NF-κB has proapoptotic effects (34,40,41). The PICex-induced activation of NF-κB via TLR3 could therefore contribute to the presently observed proapoptotic effects of TLR3 stimulation.

Cytosolic accumulation of dsRNA induces a more intense activation of NF-κB and IRF-3 and a higher prevalence of apoptosis compared with PICex, suggesting that NF-κB and IRF-3 may play a role in this process. Inhibition of NF-κB activation, however, did not protect against PICin-induced cell death. In other cell types, TLR3-mediated IRF-3 and NF-κB activation transactivates IFN-β and -α. Once secreted, IFN-α/β act in an autocrine/paracrine manner, leading to the upregulation of a secondary set of genes involved in antiviral responses and in triggering apoptosis (42). Part of the observed discrepancy between the effects of external versus internal dsRNA could be due to the marked PICin-induced upregulation of IFN-β mRNA expression and secretion by the β-cells. In line with this possibility, suppression of the IRF-3 signaling pathway abolished secretion of IFN-β and prevented PICin-induced islet cell dysfunction and death, whereas it had only a minor effect on the deleterious effects of PICex+IFN-γ. In addition, blocking type I IFNs signaling by use of IFNAR1−/− mice or by an antibody against IFN-β prevents the detrimental effects of PICin, confirming that IFN-α/β signaling contributes to β-cell death in an autocrine/paracrine manner. Type I IFNs may have a dual biological role: elicit an antiviral state in uninfected cells while selectively inducing apoptosis in virally infected cells, thus limiting viral replication and spreading of the infection. Depending on the type of viral infection and on the cellular context, IFN-α/β effects may favor tissue damage or eradication of the viral infection (43). Type I IFNs have been implicated in the development of type 1 diabetes (21,44); high levels of these cytokines were detected in the pancreas or islets of type 1 diabetic patients (20,45), and IFN-α was proposed as a mediator of viral-induced experimental type 1 diabetes (21,22,46).

Viral infection inhibits protein synthesis through phosphorylation of eIF2α by PKR. PKR activation has been involved in islet cell defense during viral infection (47), and we presently observed that PICin triggers a marked translational repression associated with eIF2α phosphorylation.

eIF2α phosphorylation may also occur in response to other cellular stresses, resulting from activation of kinases such PKR-like ER kinase, which responds to ER stress. Pancreatic β-cells are highly sensitive to ER stress, and a tight control of ER homeostasis is crucial to preserve β-cell function and survival (48), and prolonged eIF2α phosphorylation was described as proapoptotic in β-cells (31). It is conceivable that a massive and prolonged PICin-triggered production of type I IFN–induced proteins, such as cytokines, chemokines, and HLA-1 components (16,28), overloads the ER capacity triggering an excessive ER stress response and favoring β-cell apoptosis. In line with this hypothesis, PICin, but not PICex, upregulates ER stress marker genes in β-cells (present data). Additional experiments are required to validate the role of ER stress in PICin-triggered apoptosis.

In summary, we demonstrate that external and internal dsRNA trigger β-cell apoptosis by essentially different mechanisms (online appendix Fig. S4). Both external and internal dsRNA induce activation of NF-κB and IRF-3 in pancreatic β-cells, but activation of these transcription factors is entirely dependent of TLR3 signaling for external, but not for internal, dsRNA. In line with these observations, the TLR3 pathway is the key mediator of β-cell apoptosis triggered by PICex, while IRF-3 signaling plays a major role in PICin-induced islet cell dysfunction and death. Internal dsRNA induces a massive production of type I IFNs, which contributes to PICin-induced apoptosis.

The present work represents the first detailed mechanistic study on innate immunity signaling pathways activated by dsRNA in pancreatic β-cells and clarifies part of the complex molecular responses of β-cells faced with viral components in the intra- or extracellular space. We propose that activation of immune pathways and production of type I IFNs by β-cells play a relevant role in the development of insulitis and eventually type 1 diabetes. As recently described by Baccala et al. (49), type I IFNs induction by nucleic acids or apoptotic materials via TLR-dependent and -independent pathways might be a central pathogenic event in autoimmunity.

Published ahead of print at http://diabetes.diabetesjournals.org on 25 January 2008. DOI: 10.2337/db07-0844.

Additional information can be found in an online appendix at http://dx.doi.org/10.2337/db07-0844.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

This study was supported by grants from the European Foundation for the Study of Diabetes/Lilly European Diabetes Research Programme, the “Fonds David et Alice Van Buuren,” the “Fonds de la Recherche Scientifique Médicale” (convention no. 3.4514.03/avenant 3.4554.05), the “Actions de Recherche Concertées” (convention no. 04/09-311), the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State (interuniversitaire attractiepolen P6/40) and The European Union Project SAVEBETA (contract no. 036903 in the FP6 of the European Commission).

We thank Prof. T. Taniguchi (University of Tokyo) for kindly providing the IRF-3 knockout mice. We are also grateful to N. El Amrite, J. Schoonheydt, M. Urbain, and G. Vandenbroeck for expert technical assistance.

1.
Jun HS, Yoon, JW: A new look at viruses in type 1 diabetes.
Diabetes Metab Res Rev
19
:
8
–31,
2003
2.
Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, Akerblom, HK: Environmental triggers and determinants of type 1 diabetes.
Diabetes
54
(Suppl. 2):
S125
–S136,
2005
3.
Roivainen, M: Enteroviruses: New findings on the role of enteroviruses in type 1 diabetes.
Int J Biochem Cell Biol
38
:
721
–725,
2006
4.
Sarmiento L, Cabrera-Rode E, Lekuleni L, Cuba I, Molina G, Fonseca M, Heng-Hung L, Borroto AD, Gonzalez P, Mas-Lago P, Diaz-Horta, O: Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of type 1 diabetes.
Autoimmunity
40
:
540
–545,
2007
5.
Jun HS, Yoon, JW: The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals.
Diabetologia
44
:
271
–285,
2001
6.
Jacobs BL, Langland, JO: When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA.
Virology
219
:
339
–349,
1996
7.
Majde JA, Guha-Thakurta N, Chen Z, Bredow S, Krueger, JM: Spontaneous release of stable viral double-stranded RNA into the extracellular medium by influenza virus-infected MDCK epithelial cells: implications for the viral acute phase response.
Arch Virol
143
:
2371
–2380,
1998
8.
Sobel DO, Newsome J, Ewel CH, Bellanti JA, Abbassi V, Creswell K, Blair, O: Poly I:C induces development of diabetes mellitus in BB rat.
Diabetes
41
:
515
–520,
1992
9.
Ewel CH, Sobel DO, Zeligs BJ, Bellanti, JA: Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat.
Diabetes
41
:
1016
–1021,
1992
10.
Heitmeier MR, Scarim AL, Corbett, JA: Double-stranded RNA inhibits beta-cell function and induces islet damage by stimulating beta-cell production of nitric oxide.
J Biol Chem
274
:
12531
–12536,
1999
11.
Scarim AL, Arnush M, Blair LA, Concepcion J, Heitmeier MR, Scheuner D, Kaufman RJ, Ryerse J, Buller RM, Corbett, JA: Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis.
Am J Pathol
159
:
273
–283,
2001
12.
Beutler, B: Inferences, questions and possibilities in toll-like receptor signalling.
Nature
430
:
257
–263,
2004
13.
Rasschaert J, Ladriere L, Urbain M, Dogusan Z, Katabua B, Sato S, Akira S, Gysemans C, Mathieu C, Eizirik, DL: Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-gamma-induced apoptosis in primary pancreatic beta-cells.
J Biol Chem
280
:
33984
–33991,
2005
14.
Vives-Pi M, Somoza N, Fernandez-Alvarez J, Vargas F, Caro P, Alba A, Gomis R, Labeta MO, Pujol-Borrell, R: Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells.
Clin Exp Immunol
133
:
208
–218,
2003
15.
Wen L, Peng J, Li Z, Wong, FS: The effect of innate immunity on autoimmune diabetes and the expression of toll-like receptors on pancreatic islets.
J Immunol
172
:
3173
–3180,
2004
16.
Ylipaasto P, Kutlu B, Rasilainen S, Rasschaert J, Salmela K, Teerijoki H, Korsgren O, Lahesmaa R, Hovi T, Eizirik DL, Otonkoski T, Roivainen, M: Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets.
Diabetologia
48
:
1510
–1522,
2005
17.
Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya, T: TICAM-1, an adaptor molecule that participates in toll-like receptor 3-mediated interferon-beta induction.
Nat Immunol
4
:
161
–167,
2003
18.
Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira, S: Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
J Immunol
169
:
6668
–6672,
2002
19.
Taniguchi, T, Takaoka, A: The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors.
Curr Opin Immunol
14
:
111
–116,
2002
20.
Huang X, Yuang J, Goddard A, Foulis A, James RF, Lernmark A, Pujol-Borrell R, Rabinovitch A, Somoza N, Stewart, TA: Interferon expression in the pancreases of patients with type I diabetes.
Diabetes
44
:
658
–664,
1995
21.
Devendra D, Jasinski J, Melanitou E, Nakayama M, Li M, Hensley B, Paronen J, Moriyama H, Miao D, Eisenbarth GS, Liu, E: Interferon-α as a mediator of polyinosinic:polycytidylic acid–induced type 1 diabetes.
Diabetes
54
:
2549
–2556,
2005
22.
Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S, Odermatt B, Conrad C, Ittner LM, Bauer S, Luther SA, Uematsu S, Akira S, Hengartner H, Zinkernagel RM: Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease.
Nat Med
11
:
138
–145,
2005
23.
Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3.
Nature
413
:
732
–738,
2001
24.
Pipeleers DG, in’t Veld PA, Van de Winkel M, Maes E, Schuit FC, Gepts W: A new in vitro model for the study of pancreatic A and B cells.
Endocrinology
117
:
806
–816,
1985
25.
Hoorens A, Van de Casteele M, Kloppel G, Pipeleers, D: Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program.
J Clin Invest
98
:
1568
–1574,
1996
26.
Liu D, Darville M, Eizirik, DL: Double-stranded ribonucleic acid (RNA) induces beta-cell Fas messenger RNA expression and increases cytokine-induced beta-cell apoptosis.
Endocrinology
142
:
2593
–2599,
2001
27.
Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik, DL: Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays.
Diabetes
50
:
909
–920,
2001
28.
Rasschaert J, Liu D, Kutlu B, Cardozo AK, Kruhoffer M, ORntoft TF, Eizirik, DL: Global profiling of double stranded RNA- and IFN-gamma-induced genes in rat pancreatic beta cells.
Diabetologia
46
:
1641
–1657,
2003
29.
Pirot P, Eizirik DL, Cardozo, AK: Interferon-gamma potentiates endoplasmic reticulum stress-induced death by reducing pancreatic beta cell defence mechanisms.
Diabetologia
49
:
1229
–1236,
2006
30.
Dogusan Z, Hooghe R, Verdood P, Hooghe-Peters, EL: Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes.
J Neuroimmunol
120
:
58
–66,
2001
31.
Cnop M, Ladriere L, Hekerman P, Ortis F, Cardozo AK, Dogusan Z, Flamez D, Boyce M, Yuan J, Eizirik, DL: Selective inhibition of EIF2alpha dephosphorylation potentiates fatty acid-induced ER stress and causes pancreatic beta-cell dysfunction and apoptosis.
J Biol Chem
282
:
3989
–3997,
2007
32.
Eizirik, DL: Interleukin-1 beta induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis.
Autoimmunity
10
:
107
–113,
1991
33.
Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik, DL: Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis.
Diabetes
50
:
2219
–2224,
2001
34.
Liu D, Cardozo AK, Darville MI, Eizirik DL: Double-stranded RNA cooperates with interferon-gamma and IL-1 beta to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic beta-cells: potential mechanisms for viral-induced insulitis and beta-cell death in type 1 diabetes mellitus.
Endocrinology
143
:
1225
–1234,
2002
35.
Servant MJ, Grandvaux N, Hiscott J: Multiple signaling pathways leading to the activation of interferon regulatory factor 3.
Biochem Pharmacol
64
:
985
–992,
2002
36.
Rhodes CJ, Taylor KW: Effect of interferon and double-stranded RNA on B-cell function in mouse islets of Langerhans.
Biochem J
228
:
87
–94,
1985
37.
Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M: Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus.
J Biol Chem
280
:
5571
–5580,
2005
38.
Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA: Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.
Nat Med
10
:
1366
–1373,
2004
39.
Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M Jr., Lemon SM: Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.
Proc Natl Acad Sci U S A
102
:
2992
–2997,
2005
40.
Robbins MA, Maksumova L, Pocock E, Chantler, JK: Nuclear factor-kappaB translocation mediates double-stranded ribonucleic acid-induced NIT-1 beta-cell apoptosis and up-regulates caspase-12 and tumor necrosis factor receptor-associated ligand (TRAIL).
Endocrinology
144
:
4616
–4625,
2003
41.
Gysemans, CA, Ladriere L, Callewaert H, Rasschaert J, Flamez D, Levy DE, Matthys P, Eizirik DL, Mathieu C: Disruption of the γ-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of β-cells.
Diabetes
54
:
2396
–2403,
2005
42.
Doyle SE, O'Connell R, Vaidya SA, Chow EK, Yee K, Cheng G: Toll-like receptor 3 mediates a more potent antiviral response than toll-like receptor 4.
J Immunol
170
:
3565
–3571,
2003
43.
Heylbroeck C, Balachandran S, Servant MJ, DeLuca C, Barber GN, Lin R, Hiscott, J: The IRF-3 transcription factor mediates Sendai virus-induced apoptosis.
J Virol
74
:
3781
–3792,
2000
44.
Pelegrin M, Devedjian JC, Costa C, Visa J, Solanes G, Pujol A, Asins G, Valera A, Bosch F: Evidence from transgenic mice that interferon-beta may be involved in the onset of diabetes mellitus.
J Biol Chem
273
:
12332
–12340,
1998
45.
Foulis AK, Farquharson MA, Meager A: Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus.
Lancet
2
:
1423
–1427,
1987
46.
Devendra D, Eisenbarth GS: Interferon alpha: a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity.
Clin Immunol
111
:
225
–233,
2004
47.
Flodstrom-Tullberg M, Hultcrantz M, Stotland A, Maday A, Tsai D, Fine C, Williams B, Silverman R, Sarvetnick N: RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection.
J Immunol
174
:
1171
–1177, 2005
48.
Scheuner D, Mierde DV, Song B, Flamez D, Creemers JW, Tsukamoto K, Ribick M, Schuit FC, Kaufman RJ: Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis.
Nat Med
11
:
757
–764,
2005
49.
Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN: TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
Nat Med
13
:
543
–551,
2007

Supplementary data